STARTRK-2
Hoffmann-La Roche
Hoffmann-La Roche
University Health Network, Toronto
Pfizer
Adela, Inc
UNC Lineberger Comprehensive Cancer Center
Washington University School of Medicine
Incyte Corporation
University of Exeter
Rigshospitalet, Denmark
Tempus AI
Intensity Therapeutics, Inc.
Cedars-Sinai Medical Center
Checkpoint Therapeutics, Inc.
University Health Network, Toronto
Massachusetts General Hospital
Cyteir Therapeutics, Inc.
Cedars-Sinai Medical Center
Presage Biosciences
Celldex Therapeutics
CytomX Therapeutics
Eastern Cooperative Oncology Group
Seagen Inc.
Fate Therapeutics
Presage Biosciences
Incyte Corporation
Hospices Civils de Lyon
Institut Bergonié
Tocagen Inc.
University of California, San Diego
Stanford University
Amgen
Lytix Biopharma AS
sigma-tau i.f.r. S.p.A.
Wuxi No. 4 People's Hospital
Stanford University
Valerio Therapeutics
Washington University School of Medicine
University of Chicago
Altor BioScience
Memorial Sloan Kettering Cancer Center
Children's Oncology Group
Ontario Clinical Oncology Group (OCOG)
National Cancer Institute (NCI)
Cancer Research UK
Case Comprehensive Cancer Center
Mt. Sinai Medical Center, Miami